Funder
Universitair Ziekenhuis Gent
Agentschap voor Innovatie door Wetenschap en Technologie
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Sidi V, Roilides E, Bibashi E, Gompakis N, Tsakiri A, Koliouskas D. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and Gram-positive bacteremia. J Chemother. 2000;12(4):326–31.
2. Cavalcanti AB, Goncalves AR, Almeida CS, Bugano DDG, Silva E. Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev. 2010;6:6–8.
3. Sanofi. Targocid 400mg: summary of product characteristics. 2017.
4. Ramos-Martín V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, et al. Pharmacodynamics of teicoplanin against MRSA. J Antimicrob Chemother. 2017;72(12):3382–9.
5. Boast A, Gwee A. Teicoplanin: should we be doing routine therapeutic drug monitoring in children? Pediatr Infect Dis J. 2017;36(11):1110.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献